Last reviewed · How we verify
Danicopan: Powder-In-Capsule 2
At a glance
| Generic name | Danicopan: Powder-In-Capsule 2 |
|---|---|
| Also known as | ALXN2040, ACH-0144471 (formerly) |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Danicopan: Powder-In-Capsule 2 CI brief — competitive landscape report
- Danicopan: Powder-In-Capsule 2 updates RSS · CI watch RSS
- Alexion Pharmaceuticals, Inc. portfolio CI